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Nucleotide excision repair (NER) is one of several DNA repair pathways that are universal throughout phylogeny. NER has a broad
substratespeciﬁcityandiscapableofremovingseveralclassesoflesionstotheDNA,includingthosethataccumulateuponexposure
to UV radiation. The loss of this activity in NER-defective mutants gives rise to characteristic sensitivities to UV that, in humans, is
manifested as a greatly elevated sensitivity to exposure to the sun. Xeroderma pigmentosum (XP), Cockaynes syndrome (CS), and
trichothiodystrophy (TTD) are three, rare, recessively inherited human diseases that are linked to these defects. Interestingly, some
of the symptoms in aﬄicted individuals appear to be due to defects in transcription, the result of the dual functionality of several
components of the NER apparatus as parts of transcription factor IIH (TFIIH). Studies with several model systems have revealed
that the genetic and biochemical features of NER are extraordinarily conserved in eukaryotes. One system that has been studied very
closelyisthebuddingyeastSaccharomycescerevisiae.WhilemanyyeastNERmutantsdisplaytheexpectedincreasesinUVsensitivity
and defective transcription, other interesting phenotypes have also been observed. Elevated mutation and recombination rates, as
well as increased frequencies of genome rearrangement by retrotransposon movement and recombination between short genomic
sequences have been documented. The potential relevance of these novel phenotypes to disease in humans is discussed.
DNA REPAIR AND DISEASE
The maintenance of the integrity of DNA is of a para-
mountbiologicalimportanceasitservesasthecentralrepos-
itory for all genetic information. A network of biochemical
pathways exists in all cells to maintain the informational and
structural ﬁdelity of DNA. These pathways are characterized,
in part, by the types of modiﬁcations to the DNA to which
they respond. The dissection of these pathways has involved
a coordinated biochemical, genetic, and molecular biologi-
cal approach where speciﬁc enzymatic defects are correlated
with mutations at particular chromosomal loci, and distinc-
tive cellular phenotypes. In humans, the speciﬁc DNA repair
defects have been correlated with particular inherited dis-
eases. Hereditary nonpolyposis colorectal cancer, for exam-
ple, is a disorder associated with mutations in genes encod-
ing components of the mismatch repair apparatus that lead
toprofounddefectsincellularmismatchrepair,andincreases
in genome instability [1]. Similarly, a trio of phenotypically
disparate diseases, XP, CS, and TTD have been connected
with mutations in genes that encode subunits of the NER
and TFIIH apparatus, that confer measurable defects in NER
andtranscription[2,3,4].Thebroadsymptomologyofthese
diseases most likely reﬂects the multiple biochemical de-
fects caused by the mutations, some of which have not been
extensively explored. This work focus on some of the less
described eﬀects of mutations in the NER/TFIIH apparatus
on genome stability, and their potential implications with re-
spect to human disease.
NUCLEOTIDE EXCISION REPAIR
NER plays a critical role in the maintenance of genomic
integrity because of its broad substrate speciﬁty. It plays an
important role in the removal of such diverse lesions as UV
l i g h ti n d u c e dp h o t o p r o d u c t sa sw e l la sc h e m i c a l l yi n d u c e d
bulky adducts, crosslinks, and oxidized bases. NER has been
functionally conserved throughout phylogeny, although the
apparatus in prokaryotes and eukaryotes is substantially dif-
ferent.NERineukaryotesinvolvestheconcertedactionofup
to 30 proteins and has been reconstituted in vitro[5, 6].NER
occurs in the context of two distinct pathways related to the
way the lesions are identiﬁed. General genome repair (GGR)
respondstogenome-widedamage,whichinmammalsisrec-
ognized by the XPC/HHR23B complex [7]. Transcription
coupled repair (TCR) is focused exclusively on the repair of
lesionsonthetranscribedstrandofactivelytranscribedgenes
[8],andisthoughttoinvolverecognitionofRNApolymerase
II stalled at a lesion by the CSA and CSB proteins [9, 10].
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including the single-stranded DNA binding protein RPA and
the core of the TFIIH complex at the site of the lesion [11].
ThiscomplexunwindstheDNAsurroundingthelesioninan
ATP-dependent process that involves the helicase activities of
the XPB and XPD proteins, components of the TFIIH core
complex [12, 13]. Interestingly, only the helicase activity of
XPB is required for TFIIH-mediated melting of promoter
DNA during the initiation of transcription, while XPD he-
licase activity plays a minor role in RNA polymerase II pro-
moter escape [14]. Two structure-speciﬁc endonucleases, the
ERCC1/XPF heterodimer, that cleaves on the 3  side of the
lesion, and XPG, that cleaves on the 5  side of the lesion, are
responsible for the removal of a 24–32 base oligonucleotide
containing the lesion [15, 16]. The resulting gap is ﬁlled by
DNA polymerases δ and ε, and repair is completed by liga-
tion [5].
NER PHOTOSENSITIVITY SYNDROMES
XP, CS, and TTD have been ascribed to changes in NER
and TFIIH function. Complementation analysis, conducted
by analyzing the phenotypes of cells derived from the fusion
of cells from diﬀerent patients, identiﬁed several comple-
mentationgroupsforeachdisease[11].Sevencomplementa-
tiongroups,designatedXP-AthroughXP-G,havebeeniden-
tiﬁed for XP. Two complementation groups, CS-A and CS-B,
have been identiﬁed for CS. Three complementation groups,
XP-B, XP-D, and XP-G, have been determined for the com-
bined CS/XP patients. Three complementation groups, XP-
B, XP-D, and TTD-A, have been identiﬁed for TTD. Most of
the genes corresponding to these complementation groups
have been cloned and the mutations responsible for disease
in individual kindreds have been identiﬁed.
XP, CS, and TTD patients have distinct symptoms that
likely reﬂect the participation of the mutant proteins in mul-
tiple biochemical processes. In patients, symptoms can often
be correlated with speciﬁc biochemical defects. An example
for each disease is listed below. XP patients exhibit distinct
alterations of the texture and pigmentation of the skin that
are related to exposure to the sun. They are also enormously
predisposed to both sunlight-induced and internal cancers,
consistent with defects in NER [17]. For example, an 80%
reduction in cellular NER activity in an XP patient homozy-
gous for a particular XPF mutation correlates well with the
acute reactions to sun exposure and skin cancer that were
also observed [18]. CS patients present symptoms of poor
growthanddevelopmentaldeformitythataremostlikelydue
to defective transcription. Accordingly, extracts of cells from
patients with particular CSA and CSB mutations have been
shown to support reduced levels of RNA polymerase II me-
diated transcription, as have cells from patients with com-
bined XP/CS disease that are due to a mutation in XPB [19].
TTD patients suﬀer from brittle hair and nails, scaly skin and
developmental abnormalities that are probably related to de-
fects in NER and transcription. In support of this, fever in-
ducible hair loss was correlated with temperature sensitive
transcription and NER in the cells of patients with speciﬁc
XPD mutations [20].
STUDIES WITH MODEL SYSTEMS
The extraordinary level of conservation of the NER and
TFIIH apparatus among eukaryotes permits the extensive
use of model systems to better explore the genetic and bio-
chemical control of theses processes. Studies in rodents, ﬂies,
plants, and fungi have all contributed to the understanding
of the role played by the NER and TFIIH apparatus in eu-
karyotes [21, 22, 23, 24, 25, 26]. However, trangenic mice
and budding yeast have been particularly helpful in study-
ing NER and TFIIH at the molecular level, as well as their
eﬀects on the phenotype of the organism. For example, in a
recentstudy,isogenicstrainsofmicehomozygousfornullal-
leles of XPA or CSB were found to be extremely sensitive to a
carcinogen that forms bulky adducts on DNA, while an XPC
null strain was not [27]. This suggests that XPA-dependent
a n dC S B - d e p e n d e n tT C Ri sc r i t i c a lf o rs u r v i v a lt oe x p o s u r e
to an important class of carcinogens, while XPC-dependent
GGR is not. Such studies are very important in determining
how mammals respond to particular types of DNA damage.
Mice have also been used to further explore the phenotypic
eﬀects of NER mutations known to cause disease in humans.
Forexample,astrainofmousewascreatedthatwashomozy-
gous for an XPD mutation analogous to the one found in
several NER-deﬁcient TTD patients [28] .T h em i c ee x h i b -
ited hypersensitivity to UV exposure and a cellular NER de-
fect that was very similar to the TTD symptomology but,
also exhibited a marked propensity toward UV-induced and
carcinogen-induced skin cancer that was not observed in pa-
tients. This suggests the possibility that the NER defects ob-
served in TTD patients could lead to cancer, an observation
of potential clinical importance.
ThestudyofNERandTFIIHinbuddingyeastandmam-
malian cells has been essentially contemporaneous. The ob-
servation that NER and transcription are genetically and
biochemically linked occurred nearly simultaneously in the
two systems, signiﬁcantly accelerating the description of eu-
karyotic NER and transcription initiation at the molecular
level [29, 30]. The degree of similarity between the appa-
ratus in humans and yeast is extraordinary, permitting in-
vestigators to examine the impact of disease causing alleles
of human NER genes on yeast. In one study, two TTD al-
leles of XPD were unable to complement the lethal eﬀect
of a null allele of the RAD3 gene, the budding yeast ho-
molog of XPD, while wild-type and helicase-defective alle-
les of XPD were able to complement [31]. Since the essen-
tial function of Rad3/XPD is thought to be its role in tran-
scriptioninitiation,theauthorsconcludedthattheTTDalle-
les confer a transcription defect, and, therefore, that the dis-
ease may be due to defective transcription of a critical gene,
or genes.
NER, TFIIH, AND THE MAINTENANCE OF GENOME
STABILITY IN BUDDING YEAST
The careful study of NER in budding yeast has revealed
its impact on cellular processes yet to be recognized in other
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Figure 1. Amino acid changes in the human XPD and budding yeast Rad3 helicases that lead to phenotypic changes. The primary amino acid sequences of
human XPD and yeast Rad3 are represented by the black bar. The seven conserved helicase domains are represented by white boxes and are named according
to the accepted nomenclature [42]. The positions of these domains in the primary sequence are listed in bold print as described in [46]. Positions of altered
residues in the primary sequence of XPD in XP, XP/CS, and TTD patients [44] are marked with a light hash mark above the black bar. The corresponding
diseases are marked with an X for XP, a C for XP/CS, and a T for TTD. The amino acid changes are listed in parentheses. Changes in the Rad3 primary
sequence [38, 39] are represented by hash marks below the black bar. The corresponding phenotypic changes are denoted by a U for UV sensitive, an R for
elevated recombination, and/or mutation, and a T for transcription defective. Corresponding amino acid changes are listed in parentheses.
insightintoclinicallyimportantrolesforthehumanNERap-
paratusthathaveyettobecarefullyexplored,especiallywhen
the disease phenotype is complex as in CS and TTD. An im-
portant example is provided by the RAD1 and RAD10 genes,
homologs of XPF and ERCC1. Null mutations in RAD1 and
RAD10 confer profound defects in several diﬀerent types
of homologous recombination [32, 33]. Studies analyzing
the recombinational repair of deﬁned double-strand breaks
(DSBs) revealed that RAD1 and RAD10 were required to re-
move nonhomologous sequences from the ends of recom-
bining molecules, an important step in the creation of cer-
taingenomerearrangments[34].RAD1andRAD10alsoplay
a critical role in recombination between short sequences,
which is likely to be vital for the maintenance of genome sta-
bility [35]. All of these eﬀects are apt to be related to the role
of the Rad1-Rad10 nuclease in the cleavage of important re-
combination intermediates [34, 35, 36].
The TFIIH machinery has also been implicated in the
maintenance of genome stability. Mutant alleles of RAD3,
SSL1,a n dSSL2 (homologs of XPD, P44,a n dXPB)h a v e
been isolated that confer elevated rates of mutation and
recombination. Several rad3 mutants have been isolated
that exhibit increased rates of mutation and/or recombi-
nation but not defective transcription nor NER, indicat-
ing that Rad3 possesses important cellular activities that are
independent of transcription and NER [37, 38]. Interest-
ingly, a pair of these mutant alleles, rad3-101 (S74F) and
rad3-102 (H661Y), accumulate DSBs and are synthetically
lethal in combination with mutations in recombinational
repair genes, strongly suggesting that Rad3 inﬂuences ei-
ther the creation of DSBs, or their processing by homol-
ogous recombination [38]. Another allele of RAD3, rad3-
G595R, blocks the degradation of DSBs, which stimulates
genome rearrangement by recombination between short re-
peated sequences [35, 36, 37, 38, 39, 40, 41]. The anal-
ogous mutations in XPD are of potential medical impor-
tance as they would be within regions that encode con-
served helicase domains of the protein that are mutated in
XP, TTD, and XP/CS patients (Figure 1), [42, 43, 44]. Since
speciﬁc mutations in SSL1 and SSL2 that encode additional
members of the heteromeric core of budding yeast TFIIH
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blocking the degradation of DSBs [40, 41], it appears that
TFIIH acts to maintain genome stability by restricting re-
combination between repetitive DNA sequences. We specu-
late that SSR could potentially contribute to the symptoms
observed in XP, XP-CS, and TTD patients, as SSR in the
human genome has been found to lead to a variety of dis-
eases [45].
Recently,itwasrevealedthatbyrestrictingthemovement
of the retrotransposon Ty1, TFIIH plays an additional, crit-
ical role in the maintenance of genome stability in budding
yeast. Ty1 can move either by integrase mediated transpo-
sition, or by insertion of Ty cDNA into existing Ty or δ ele-
ments(theTy1long-terminalrepeat)byhomologousrecom-
bination [47]. Components of TFIIH were discovered to play
a role in restricting Ty mobility when speciﬁc rad3 and ssl2
mutants with increased levels of Ty1 movement were isolated
[48]. Other rad3 and ssl2 mutants that confer extreme UV
sensitivity do not stimulate Ty mobility, separating the NER
and Ty maintenance functions of these genes. The increases
in Ty mobility were correlated with a substantial elevation of
the steady-state level of Ty1 cDNA, suggesting either that the
rad3-RTT (regulator of Ty transposition) and ssl2-RTT mu-
tations increase the synthesis of Ty1 cDNA, or decrease its
degradation. Importantly, the level of Ty1 RNA and Ty1 pro-
teins remained unchanged in the rad3 and ssl2 mutants. An-
other interesting observation is that other NER genes, such
as RAD2 and RAD1 do not appear to be involved in Ty trans-
position [49].
In a subsequent study, the increased level of Ty1 cDNA
was found not to be due to increased cDNA synthesis sug-
gesting that TFIIH plays a role in the degradation of Ty1
cDNA [41]. This same study linked TFIIH-control of SSR
and Ty1 movement by showing that rad3-G595R and ssl2-
RTT increase both SSR and Ty1 movement while increasing
the stability of both Ty1 cDNA and DSBs. It remains unclear
whether TFIIH plays a direct or an indirect role in the degra-
dation of the ends of DNA molecules, however, the helicase
activities of Rad3 and Ssl2 suggest that TFIIH could play a
role in opening the ends of DNA molecules, thereby facilitat-
ing their processing by exonucleases.
Blocking the degradation of DSBs and Ty1 cDNAs could
enhance Ty1 movement and SSR in multiple ways. It could
preserve sequences at the ends of the molecules that are im-
portant for SSR and Ty1 movement. For example, a DSB
in a short repetitive sequence creates ends that are never
far from the border of homology with potential donor re-
peats, such that any erosion of the ends would signiﬁ-
cantly decrease their ability to pair and recombine. Simi-
larly, loss of the sequences at the ends of Ty1 cDNA would
block transposition by Ty1 integrase. Another way (that in-
creasing the stability of DNA ends might elevate SSR and
Ty mobility) could be by prolonging the signal that elic-
its the DNA damage checkpoint. Pausing the cell cycle for
a protracted period may improve the likelihood that the
ends of DSBs in short repeats can ﬁnd homologous se-
quences, or that the Ty1 preintegration complex can com-
plete a transposition event. Changes in checkpoint activity
have been shown to aﬀect the frequencies of other genome
rearrangements [50]. These and other mechanisms could be
working simultaneously to increase genome rearrangement
in rad3 and ssl2 mutant budding yeast. By extension, simi-
lar defects in the cells of XP, XP-CS, or TTD patients with
mutationsintheXPDorXPBgenesmightcontributetothese
diseases.
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